Laboratory Proficiency Testing Market is Anticipated to Witness High Growth Owing to Increasing Regulatory Mandates for Quality Assurance

The laboratory proficiency testing market comprises external quality assessment services offered to clinical laboratories and other medical testing facilities to check their performance and quality of test accuracy. Proficiency testing helps laboratories validate test methods and measure reliability by comparing their results against results from other labs testing the same samples. It plays a crucial role in ensuring quality laboratory practices and assists labs in achieving accreditation. Growing regulatory emphasis on quality assurance in medical testing across the healthcare industry has increased demand for proficiency testing globally. The Global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.49 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 to 2031.

Key Takeaways
Key players operating in the Laboratory Proficiency Testing market are RxBio Inc., Annova Chem Inc., Medicom Healthcare Ltd., Onconova Therapeutics, Genome Protection Inc., Grace Therapeutics LLC, Amgen Inc., Partner Therapeutics Inc., Jubilant Life Sciences Ltd., Cipla Inc., Stium Inc., Soligenix Inc., Aeolus Pharmaceuticals, PharmaIN Corp, Immune Modulators Inc. The key players in the market are focusing on broadening their service portfolios and expanding into emerging markets to leverage profitable growth opportunities.

The increasing volume of diagnostic tests performed along with rising integration of advanced technologies like AI in diagnostics is expected to create demand for continuous proficiency testing programs. Growing geriatric population and increasing incidence of chronic and infectious diseases are also impacting the diagnostic volumes positively. Leveraging new digital technologies for online assessment programs and mobile applications for real-time data analysis can help key players expand their global footprint more efficiently.

Market Drivers and Market Restrain:

Market drivers - Increasing regulatory mandates by authorities like CMS and CAP requiring regular proficiency testing are a key factor driving market growth. Strict regulations ensure better quality of diagnostic and test results. Growing public health awareness has also increased demand for quality healthcare services.

Market restraints - High costs associated with regular proficiency testing programs can restrain smaller laboratories and diagnostic centres from adopting them. Program management involving sample shipping and data analysis also requires substantial investments limiting global expansion to some extent. Lack of harmonization in regulatory guidelines across regions also poses challenges.

Segment Analysis
The laboratory proficiency testing market is dominated by the clinical diagnostics segment, which evaluates the accuracy and reproducibility of clinical pathological tests conducted by clinical laboratories. This segment is leading as clinical testing forms a major component of diagnostics performed by laboratories and needs to be regularly monitored and validated for quality assurance. The growing volume of clinical testing owing to rising disease incidence further aids the growth of this segment.

The market is also segmented by technology into PCR, spectroscopy, chromatography, immunoassay, NGS, and others. The immunoassay technology segment holds a significant share as it is widely used for assessing performance and accuracy of immunoassays carried out in clinical laboratories. It evaluates the testing of analytes through techniques like ELISA, immunofluorescence, and chemiluminescence.

Global Analysis
North America dominates the global laboratory proficiency testing market owing to stringent regulatory guidelines for quality assurance of laboratories. The presence of advanced healthcare facilities and major players in the region further supports market growth. The Asia Pacific region is projected to witness the fastest growth during the forecast period. This is attributed to rising healthcare investments, increasing disease awareness, and growing focus on improving quality standards of clinical laboratories in emerging countries like China and India. Additionally, growing collaborations between regional and international accreditation bodies are helping promote proficiency programs in the region.

Get more insights on Laboratory Proficiency Testing Market